Molecular method for the detection of Andes hantavirus infection: Validation for clinical diagnostics

Diagnostic Microbiology and Infectious Disease

Volumn 84, Issue 1, 2016, Pages 36-39

  Vial, Cecilia ^a   Martinez Valdebenito, Constanza ^b   Rios, Susana ^a   Martinez, Jessica ^a   Vial, Pablo A ^a   Ferres, Marcela ^b   Rivera, Juan C ^a   Perez, Ruth ^a   Valdivieso, Francisca ^a  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Andes virus; Diagnosis; Hantavirus; RT qPCR

Indexed keywords

VIRUS RNA;

ANDES VIRUS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DOSAGE; HANTAVIRUS PULMONARY SYNDROME; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VIRUS DETECTION; VIRUS GENOME; BLOOD; DIAGNOSTIC TEST; GENETICS; HANTAVIRUS; HANTAVIRUS INFECTIONS; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

BLOOD; DIAGNOSTIC TESTS, ROUTINE; EARLY DIAGNOSIS; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84949266873     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.07.019     Document Type: Article

References (38)

1. Castillo C. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile *. CHEST J Am Coll Chest Phys 2001, 120(2):548.
2. Duchin J., Koster F., Peters C., Simpson G., Tempest B., Zaki S.R., et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with newly recognize disease. N Engl J Med 1994, 330(14):949-955.
3. Evander M., Eriksson I., Pettersson L., Juto P., Ahlm C., Olsson G.E., et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome 2007.
4. Ferrés M., Vial P. Hantavirus infection in children. Curr Opin Pediatr 2004, 16(1):70-75.
5. Ferres M., Vial P., Marco C., Yanez L., Godoy P., Castillo C., et al. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile. J Infect Dis 2007, 195(11):1563-1571.
6. Figueiredo L.T.M., WM De Souza, Ferrés M., Enria D.A. Hantaviruses and cardiopulmonary syndrome in South America. Virus Res 2014, 187:43-54. (Elsevier B.V.).
7. Firth C., Tokarz R., Simith D.B., Nunes M.R.T., Bhat M., Rosa E.S.T., et al. Diversity and distribution of hantaviruses in South America. J Virol 2012, 86(24):13756-13766.
8. Galeno H., Mora J., Villagra E., Fernandez J., Hernandez J., Mertz G.J., et al. First human isolate of hantavirus (Andes virus) in the Americas 2002, 8(7):657-661.
9. Godoy P., Marsac D., Stefas E., Ferrer P., Tischler N.D., Pino K., et al. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome 2009, 83(10):5046-5055.
10. Hallin G.W., Simpson S.Q., Crowell R.E., James D.S., Koster F.T., Mertz G.J., et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996, 24(2):252-258.
11. Hjelle B., Torres-Pérez F. Hantaviruses in the Americas and their role as emerging pathogens 2010, 2559-2586.
12. Ibrahim S.M., Aitichou M., Hardick J., Blow J., O'Guinn M.L., Schmaljohn C. Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR. Methods Mol Biol 2011, 665:357-368.
13. Kramski M., Meisel H., Klempa B., Kru D.H., Pauli G., Nitsche A. Detection and typing of human pathogenic hantaviruses by real-time reverse transcription-PCR and pyrosequencing 2007, 1905:1899-1905.
14. Lee H.W., van der Groen G. Hemorrhagic fever with renal syndrome. Prog Med Virol 1989, 36:62-102.
15. Machado A., Souza W. Development of a one-step SYBR Green I real-time RT-PCR assay for the detection and quantitation of Araraquara and Rio Mamore hantavirus. Viruses 2013, 5:2272-2281.
16. Manigold T., Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Swiss Med Wkly 2014, 144(March):1-10.
17. Martinez V.P., Bellomo C., San Juan J., Pinna D., Forlenza R., Elder M., et al. Person-to-person transmission of Andes virus. Emerg Infect Dis 2005, 11(12):1848-1853.
18. Martinez-Valdebenito C., Calvo M., Vial C., Mansilla R., Marco C., Palma R.E., et al. Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerg Infect Dis 2014, 20(10):1629-1636.
19. Meissner J.D., Rowe J.E., Borucki M.K., St Jeor S.C. Complete nucleotide sequence of a Chilean hantavirus 2002, 89:131-143.
20. Padula P.J., Edelstein A., Miguel S.D.L., Lo N.M., Rossi C.M., Rabinovich R.D. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus 1998, 330.
21. Padula P.J., Rossi C.M., Della Valle M.O., Martinez P.V., Colavecchia S.B., Edelstein A., et al. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol 2000, 49(2):149-155.
22. Palma R.E., Polop J.J., Owen R.D., Mills J.N. Ecology of rodent-associated hantaviruses in the Southern Cone of South America: Argentina, Chile, Paraguay, and Uruguay. J Wildl Dis 2012, 48(2):267-281.
23. Pini N. Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis 2004, 17(5):427-431.
24. Plyusnin A., Vapalahti O., Vaheri A. Hantaviruses: genome structure, expression and evolution. J Gen Virol 1996, 77:2677-2687.
25. Riquelme R., Riquelme M., Torres A., Rioseco M.L., Vergara J.A., Scholz L., et al. Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis 2003, 9(11):1438-1443.
26. Sotomayor V., Olea A.M., Labraña M., Castillo C., Ortega C., Riquelme O.R., et al. Diagnosis and treatment of cardiopulmonary hantavirus syndrome: Chile-2007. Rev Chilena Infectol 2009, 26(1):68-86.
27. Souza W., Figueiredo L. Analysis of the nucleocapsid gene brings new insights to the classification of Sigmodontinae-borne hantaviruses. Arch Virol 2014, 159:2475-2477.
28. Tang K.F., Ooi E.E. Diagnosis of dengue: an update. Expert Rev Anti Infect Ther 2012, 10(8):895-907.
29. Terajima M., Hendershot J.D., Kariwa H., Koster F.T., Hjelle B., Goade D., et al. High levels of viremia in patients with the hantavirus pulmonary syndrome. J Infect Dis 1999, 180(6):2030-2034.
30. Unidad de Vigilancia/Departamento de Epidemiologia/MINSAL Executive summary of hantavirus 2012, ([in spanish]).
31. Unidad de Vigilancia/Departamento de Epidemiologia/MINSAL Weekly report 2014, ([in spanish]. Santiago: MINSAL).
32. Unidad de Vigilancia/Departamento de Epidemiologia/MINSAL Informe Semanal Semana 4 2015 2015, 1-6.
33. Vera-Otarola J., Solis L., Soto-Rifo R., Ricci E.P., Pino K., Tischler N.D., et al. The Andes hantavirus NSs protein is expressed from the viral small mRNA by a leaky scanning mechanism. J Virol 2012, 86(4):2176-2187.
34. Vial P.A., Valdivieso F., Mertz G., Castillo C., Belmar E., Delgado I., et al. Incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis 2006, 12(8):1271-1273.
35. Vial P.A., Valdivieso F., Ferres M., Riquelme R., Rioseco M.L., Calvo M., et al. High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis 2013, 57:943-951.
36. Vial P.A., Valdivieso F., Calvo M., Rioseco M.L., Riquelme R., Araneda A., et al. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome by ANDV. Antivir Ther 2015, 20:377-386.
37. Wells R.M., Sosa Estani S., Yadon Z.E., Enria D., Padula P., Pini N., et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis 1997, 3(2):171-174.
38. Xiao R., Yang S., Koster F., Ye C., Stidley C., Hjelle B. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 2006, 194(10):1403-1409.